Basilea files for market approval of Ceftobiprol in Canada |
|
|
Published
:
Tue, 17 Jul 2007 07:33 |
ZURICH (Thomson Financial) - Basilea Pharmaceutica AG said it has filed a drug submission for market approval of Ceftobiprol -- a candidate for the treatment of severe skin infections -- with the Therapeutic Products Directorate of Health in Canada.The Swiss pharma group has previously initiated approval procedures in the US and the Europe.johanna.treeck@thomson.comjmt/jagCOPYRIGHTCopyright AFX News Limited 2007. All rights reserved.The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.
|
|
|
|
|
|
|
| Stock
Quotes * |
|
NASDAQ
|
|
2792.28 |
22.57 (
0.81 %)
|
| SYMBOL (
2012-01-19 ) |
| LAST |
CHANGE
|
|
CARNIVAL
(
11:35am )
|
|
2017.00 |
46.00 (
2.42 %)
|
|
WHITBREAD
(
11:35am )
|
|
1662.99 |
33.99 (
2.09 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
IBM
(
12:34pm ) |
|
181.50 |
0.43 (
0.24 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
| Portfolio
Manager |
|
|
|